Kingchem (Liaoning) Life Science Co., Ltd. (SHE:301509)
China flag China · Delayed Price · Currency is CNY
25.81
-0.51 (-1.94%)
At close: Nov 13, 2026

SHE:301509 Balance Sheet

Millions CNY. Fiscal year is Jan - Dec.

Assets

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Cash & Equivalents
261.48370.74191.18486.9231.01213.39
Short-Term Investments
-213.2768.65---
Trading Asset Securities
658.66713.06224.2570.62104.75-
Cash & Short-Term Investments
920.141,2971,184557.52335.76213.39
Cash Growth
57.20%9.54%112.38%66.05%57.34%-20.59%
Accounts Receivable
182.38152.13112.89148.92100.65109.16
Other Receivables
0.440.450.416.0364.2413.72
Receivables
182.83152.58113.28164.95164.89122.88
Inventory
164.01144.68194.97216.88231.92178.17
Prepaid Expenses
-5.553.22---
Other Current Assets
473.7111.718.33917.9619.6715.52
Total Current Assets
1,7411,6121,5041,857752.25529.96
Property, Plant & Equipment
373.4333.42363.05391.89388.05306.15
Long-Term Investments
-308.35326.08---
Other Intangible Assets
44.4345.5147.1348.5549.8248.85
Long-Term Deferred Tax Assets
13.3617.0118.688.89.25.35
Long-Term Deferred Charges
0.120.150.190.310.450.57
Other Long-Term Assets
115.223.84.383.7710.236.63
Total Assets
2,2872,3202,2632,3111,210897.51

Liabilities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Accounts Payable
68.5142.5338.8345.0282.2654.98
Accrued Expenses
14.6123.5921.6424.0632.3122.33
Short-Term Debt
---52430
Current Portion of Long-Term Debt
----11.143.84
Current Portion of Leases
1.61.41.81.941.71.84
Current Income Taxes Payable
3.76--4.94.815.96
Current Unearned Revenue
17.1310.858.811.2414.39.38
Other Current Liabilities
28.4614.9521.5128.793.5316.61
Total Current Liabilities
134.0693.3392.57120.87264.06144.94
Long-Term Debt
----46.7938.67
Long-Term Leases
1.871.822.964.714.431.12
Long-Term Unearned Revenue
6.137.339.016.87.883.77
Long-Term Deferred Tax Liabilities
9.0410.2210.037.268.025.13
Other Long-Term Liabilities
----0.030.07
Total Liabilities
151.1112.7114.57139.63331.21193.71

Shareholders' Equity

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Common Stock
120.45120.45120.4586.0364.5364.53
Additional Paid-In Capital
1,6061,6001,5951,623528.68523.1
Retained Earnings
409473.64417.01447.23273.65112.2
Comprehensive Income & Other
0.713.3916.6414.4711.943.98
Shareholders' Equity
2,1362,2072,1492,171878.79703.8
Total Liabilities & Equity
2,2872,3202,2632,3111,210897.51

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Sep '26 Dec '25 Dec '24 Dec '23 Jan '23 Dec '21
Total Debt
3.473.214.7611.6488.0775.46
Net Cash (Debt)
916.671,2941,179545.88247.69137.93
Net Cash Growth
57.44%9.71%116.04%120.39%79.58%-28.23%
Net Cash Per Share
7.5510.749.775.442.741.54
Filing Date Shares Outstanding
120.45120.45120.45120.4590.3490.34
Total Common Shares Outstanding
120.45120.45120.45120.4590.3490.34
Working Capital
1,6071,5181,4111,736488.19385.02
Book Value Per Share
17.7318.3217.8418.029.737.79
Tangible Book Value
2,0922,1622,1022,122828.97654.95
Tangible Book Value Per Share
17.3717.9517.4517.629.187.25
Land
-2.181.371.351.331.21
Buildings
-140.71126.92110.78106.2574.34
Machinery
-534.51526.85518.12485.98337.86
Construction In Progress
-78.1176.8270.6141.4494.84